2-Bromo-6-fluoro-4-methylbenzaldehyde, 95.0%, 1g

4-Cyclopropyl-2-fluoro-benzamide, 98%, 500mg

5-(((tert-Butoxycarbonyl)amino)methyl)-2-chlorobenzoic acid, 95%, 1g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-naphthalenecarboxaldehyde, 97%, 250mg

3-chloro-2-[(piperidin-4-yl)methoxy]pyridine hydrochloride, 1g

N,N,2,2-Tetramethyl-1,3-propanediamine>98.0%(GC)(T)500mL

n-Dodecane, min. 95%, for synthesis, 100 ml, glass packaging

(4-Methylpyrimidin-2-yl)methanol, 95.0%, 250mg

4-Methyl-1H-indol-6-amine, 98%, 250mg

(4aS,9bR)-Ethyl 6-bromo-5-(2-(methylamino)-2-oxoethyl)-3,4,4a,5-tetrahydro-1H-pyrido[4,3-b]indole-2(9bH)-carboxylate, 97.0%, 250mg

2,6-Di-tert-butyl-4-vinylphenol, 95.0%, 5g

4-Chloro-3-ethoxyaniline, 95%, 5g

Ethyl 2-bromo-5-fluoroisonicotinate, 95%, 1g